Personalized Health Project: An Action Summit for Life Science Leaders
The Personalized Health Project and video was sponsored by the Ewing Marion Kauffman Foundation.
"The Conundrum of Unexpected Complexity": Andrew Kasarskis, PhD, Head of Strategic Initiatives, Sage BioNetworks -- and Eric Schadt, PhD, CSO, Pacific Biosystems (appearing from Boston by Skype)
"Big Pharma in an Age of Personalized Health": Greg Simon, Senior Vice President for Worldwide Policy, Pfizer; former President, Faster Cures
Two entrepreneurial presentations
Cellular Dynamics International: Robert J. Paley, CEO
Massive Health: Aza Raskin, co-founder; former Creative Lead for Firefox
Andrew Kasarskis, PhD is Head of Strategic Initiatives at Sage BioNetworks.
Robert J. Palay
Robert J. Paley is the CEO of Cellular Dynamics International.
Aza Raskin is the co-founder and former Creative Lead for Firefox.
Eric Schadt, PhD, is Director of the Icahn Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences, and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai. Dr. Schadt is an expert on the generation and integration of very large-scale sequence variation, molecular profiling and clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology. He has published more than 200 peer-reviewed papers in leading scientific journals, and contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity, and Alzheimer’s disease. Dr. Schadt is also a founding member of Sage Bionetworks, an open-access genomics initiative designed to build and support databases and an accessible platform for creating innovative dynamic disease models. Prior to joining Mount Sinai in 2011, he was Chief Scientific Officer at Pacific Biosciences, the next-generation sequencing technology provider. Previously, Dr. Schadt was Executive Scientific Director of Genetics at Rosetta Inpharmatics, a subsidiary of Merck & Co., Inc. in Seattle, and before Rosetta, Dr. Schadt was a Senior Research Scientist at Roche Bioscience. He received his B.A. in applied mathematics and computer science from California Polytechnic State University, his M.A. in pure mathematics from University of California, Davis, and his Ph.D. in bio-mathematics from University of California, Los Angeles (requiring Ph.D. candidacy in molecular biology and mathematics).
Greg Simon is President of FasterCures/The Center for Accelerating Medical Solutions, a nonprofit, nonpartisan organization that examines the medical research and development process to discover and promote ways to speed the discovery, development and deployment of new medical treatment for today's deadly diseases.
Prior to joining FasterCures in 2003, Mr. Simon was a principal at Infotech Strategies, a Washington, D.C. consulting firm with expertise in health technology, biotech, education technology and communication technology. From 1993 to 1997, Mr. Simon was Chief Domestic Policy Advisor to Vice President Al Gore, specifically with regard to economic, science, and technology issues, and he played a leading role in a variety of related White House policies and programs.